Gland Pharma Ltd.

₹1469.4

Gland Pharma Ltd.

₹1469.4

₹1469.4

9.1 (0.62%) - 17 May 2025 04:20 PM

About Company

Gland Pharma Limited is focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. It has established a portfolio of injectable products across various therapeutic areas and delivery systems. It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. It is expanding its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products as well as new delivery systems such as pens and cartridges.

Market Cap. ₹ 24,209 Cr.
52 Week - High/Low ₹ 2,221/1,278
P/E Ratio 21.46
P/B Ratio 2.67
Enterprise Value ₹ 22,592 Cr.
ROE % 12.31
RSI Value 78.95
EMA 50 1487.12
EMA 200 1633.97
Market Cap. ₹ 24,209 Cr.
52 Week - High/Low ₹ 2,221/1,278
P/E Ratio 34.15
P/B Ratio 2.76
Enterprise Value ₹ 22,709 Cr.
ROE % 9.26
RSI Value 78.95
EMA 50 1487.12
EMA 200 1633.97

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.